<DOC>
	<DOCNO>NCT00340210</DOCNO>
	<brief_summary>The Columbia , MO Serum Bank initially establish 1977 part National Cancer Institute 's ( NCI ) Biological Markers Project identify serum marker breast cancer . Participants volunteer identify Breast Cancer Detection Demonstration Project ( BCDDP ) University Missouri Hospital Ellis Fischel Cancer Center Columbia , MO . A total 6,915 woman without prior history cancer , non-melanoma skin cancer , donate blood bank one occasion 1977 1987 . At time blood collection , interview information obtain include age , height , weight , reproductive menstrual history , family history breast cancer , medical condition , drug use , include oral contraceptive menopausal hormone therapy . Date last menstrual period capture woman premenopausal time blood collection . Approximately 30 % woman donate multiple sample first 10 year study , ( include 20 % 3 sample ) , collection occur average one year apart . At collection , serum aliquoted ten , 1 ml vial store -70 ( Infinite ) C NCI Repository . All woman give inform consent donate serum bank . The initial follow-up continue 12 year 1989 , 244 cancer identify . Of 6915 original participant , 79 % last see 1983 earlier , yield median follow-up time 4 year . A questionnaire mail participant annually ascertain information interim breast biopsy cancer diagnosis . Women indicate breast biopsy breast cancer send consent form permission obtain medical record include pathology report . For cancer site breast , medical record pathology report request , although date diagnosis site ascertain . Between 1999 2002 , extend follow-up Columbia , MO Serum Bank participant conduct . Of 6915 original participant , 6,720 woman blood remain included phase study . Of , 6,154 ( 91.6 % ) locate ; 566 ( 8 % ) locatable , 109 ( 2 % ) refuse participate , 40 ( &lt; 1 % ) ill participate . 1,694 woman ( 25 % ) decease . This last follow-up identify additional 1123 cancer . This cohort serum sample cohort 6720 pre- postmenopausal woman follow 20 year cancer diagnose unique resource molecular epidemiologic study explore serum marker associate cancer risk .</brief_summary>
	<brief_title>Extended Follow-up Columbia , MO Serum Bank Participants</brief_title>
	<detailed_description>The Columbia , MO Serum Bank initially establish 1977 part National Cancer Institute 's ( NCI ) Biological Markers Project identify serum marker breast cancer . Participants volunteer identify Breast Cancer Detection Demonstration Project ( BCDDP ) University Missouri Hospital Ellis Fischel Cancer Center Columbia , MO . A total 6,915 woman without prior history cancer , non-melanoma skin cancer , donate blood bank one occasion 1977 1987 . At time blood collection , interview information obtain include age , height , weight , reproductive menstrual history , family history breast cancer , medical condition , drug use , include oral contraceptive menopausal hormone therapy . Date last menstrual period capture woman premenopausal time blood collection . Approximately 30 % woman donate multiple sample first 10 year study , ( include 20 % 3 sample ) , collection occur average one year apart . At collection , serum aliquoted ten , 1 ml vial store -70 ( Infinite ) C NCI Repository . All woman give inform consent donate serum bank . The initial follow-up continue 12 year 1989 , 244 cancer identify . Of 6915 original participant , 79 % last see 1983 earlier , yield median follow-up time 4 year . A questionnaire mail participant annually ascertain information interim breast biopsy cancer diagnosis . Women indicate breast biopsy breast cancer send consent form permission obtain medical record include pathology report . For cancer site breast , medical record pathology report request , although date diagnosis site ascertain . Between 1999 2002 , extend follow-up Columbia , MO Serum Bank participant conduct . Of 6915 original participant , 6,720 woman blood remain included phase study . Of , 6,154 ( 91.6 % ) locate ; 566 ( 8 % ) locatable , 109 ( 2 % ) refuse participate , 40 ( &lt; 1 % ) ill participate . 1,694 woman ( 25 % ) decease . This last follow-up identify additional 1123 cancer . This cohort serum sample cohort 6720 pre- postmenopausal woman follow 20 year cancer diagnose unique resource molecular epidemiologic study explore serum marker associate cancer risk .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>Not list .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 24, 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Etiology</keyword>
	<keyword>Hormones</keyword>
	<keyword>Prospective Study</keyword>
</DOC>